Anant Labs

Peramivir

CAS 330600-85-6

Overview

Peramivir (trade name Rapivab) is an antiviral drug developed by BioCryst Pharmaceuticals for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. It is approved for intravenous administration

Anant Labs manufacture and furnish high quality Peramivir impurities for global markets. Our Peramivir EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Peramivir
In Stock

Peramivir

CAS 330600-85-6In Stock
WhatsApp
Technical Data
CAS330600-85-6
Mol. FormulaC15H28N4O4
Mol. Weight328.413 g/mol
IUPAC(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid
SMILESCCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C
InChIInChI=1S/C15H28N4O4/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19)/t9-,10+,11+,12-,13+/m0/s1
InChI KeyXRQDFNLINLXZLB-CKIKVBCHSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms
Peramivir330600-85-6BCX-1812RapiactaRWJ-270201Peramivir anhydrousRAPIVABBCX 1812BCX18129ZS94HQO3B

Looking for a specific reference standard?

Tell us what you need. Our team responds within one business day.